Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection

被引：0

作者：

Rossana Verónica Mendoza López

José Eduardo Levi

José Eluf-Neto

Rosalina Jorge Koifman

Sergio Koifman

Maria Paula Curado

Pedro Michaluart-Junior

David Livingstone Alves Figueiredo

Fabiano Pinto Saggioro

Marcos Brasilino de Carvalho

Luiz Paulo Kowalski

Márcio Abrahão

Francisco de Góis-Filho

Eloiza Helena Tajara

Tim Waterboer

Paolo Boffetta

Paul Brennan

Victor Wünsch-Filho

机构：

[1] Universidade de São Paulo,Faculdade de Saúde Pública

[2] Hospital de Câncer de Barretos,Instituto de Ensino e Pesquisa

[3] Universidade de São Paulo,Instituto de Medicina Tropical

[4] Universidade de São Paulo,Faculdade de Medicina

[5] Fundação Oswaldo Cruz,Escola Nacional de Saúde Pública

[6] Hospital Araujo Jorge,Hospital das Clínicas, Faculdade de Medicina

[7] International Prevention Research Institute,Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto

[8] Universidade de São Paulo,Hospital São Paulo

[9] Universidade de São Paulo,The Tisch Cancer Institute

[10] Hospital Heliópolis,undefined

[11] Hospital do Câncer A.C. Camargo,undefined

[12] Universidade Federal de São Paulo,undefined

[13] Instituto do Câncer Arnaldo Viera de Carvalho,undefined

[14] Faculdade de Medicina de São José do Rio Preto,undefined

[15] German Cancer Research Center (DKFZ),undefined

[16] Mount Sinai School of Medicine,undefined

[17] International Agency for Research on Cancer,undefined

来源：

Cancer Causes & Control | 2014年 / 25卷

关键词：

Human papillomavirus; Serology; Prognosis; Head and neck cancer; Prevalence;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：461 / 471

页数：10

共 50 条

[21] Increase in head and neck cancer in younger patients due to human papillomavirus (HPV)
Young, David
Xiao, Christopher C.
Murphy, Benjamin
Moore, Michael
Fakhry, Carole
Day, Terry A.
ORAL ONCOLOGY, 2015, 51 (08) : 727 - 730
[22] Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer
Wu, A.
Zeng, Q.
Kang, T. H.
Peng, S.
Roosinovich, E.
Pai, S. I.
Hung, C-F
GENE THERAPY, 2011, 18 (03) : 304 - 312
[23] Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer
A Wu
Q Zeng
T H Kang
S Peng
E Roosinovich
S I Pai
C-F Hung
Gene Therapy, 2011, 18 : 304 - 312
[24] Human papillomavirus (HPV) infection in head and neck basaloid squamous cell carcinoma (HNBSCC).
Fan, CY
Hosal, AS
Grandis, JR
Barnes, EL
MODERN PATHOLOGY, 2001, 14 (01) : 149A - 149A
[25] Human papillomavirus (HPV) infection in head and neck basaloid squamous cell carcinoma (HNBSCC).
Fan, CY
Hosal, AS
Grandis, JR
Barnes, EL
LABORATORY INVESTIGATION, 2001, 81 (01) : 149A - 149A
[26] Prevalence of Cervical Human Papillomavirus (HPV) Infection in Vanuatu
Aruhuri, Bernadette
Tarivonda, Len
Tenet, Vanessa
Sinha, Rohit
Snijders, Peter J. F.
Clifford, Gary
Pang, James
McAdam, Margaret
Meijer, Chris J. L. M.
Frazer, Ian H.
Franceschi, Silvia
CANCER PREVENTION RESEARCH, 2012, 5 (05) : 746 - 753
[27] Low Prevalence of Human Papillomavirus (HPV) in Chinese Patients with Breast Cancer
Mou, X.
Chen, L.
Liu, F.
Shen, Y.
Wang, H.
Li, Y.
Yuan, L.
Lin, J.
Lin, J.
Teng, L.
Xiang, C.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) : 1636 - 1644
[28] Questioning the role of p16 as surrogate marker for Human papillomavirus (HPV) driven head and neck cancer
Reuter-Jessen, K.
Hugo, T.
Depenbrock, M.
Schildhaus, H. -U.
VIRCHOWS ARCHIV, 2017, 471 : S151 - S151
[29] Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer
Miguel, REV
Villa, LL
Cordeiro, AC
Prado, JCM
Sobrinho, JSP
Kowalski, LP
AMERICAN JOURNAL OF SURGERY, 1998, 176 (05): : 428 - 429
[30] HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 IN SEMEN OF PARTNERS OF WOMEN WITH HPV INFECTION
INOUE, M
NAKAZAWA, A
FUJITA, M
TANIZAWA, O
LANCET, 1992, 339 (8801): : 1114 - 1115

← 1 2 3 4 5 →